Slide 1: Compumedics Limited Business summary – October 2013
For personal use only Compumedics Limited Business summary – October 2013
Slide 2: Agenda
Agenda For personal use only • Mee;ng opens • Chairman's address • Ordinary business • Mee;ng closes
Slide 3: Strategic Value Roadmap
Strategic Value Roadmap For personal use only Core diagnos,c business Sleep – Es;mated global market USD150m Neurology – Es;mated global market USD450m Brain Research (Neuroscan) – Es;mated global market USD15m – new opportuni;es rapidly emerging Brain Blood Flow (DWL) – es;mated market USD15m, new
Slide 4: What was achieved in FY2013?
What was achieved in FY2013? For personal use only • Refinancing of primary working capital with BIBBY Financial Services Australia Pty Ltd - $2.5m facility limit, dependent on invoices presented [February 2013] • Additional short-term funding provided by existing shareholders of the Company - $300k
Slide 5: What was achieved in FY2013?
What was achieved in FY2013? For personal use only • Continued expansion into the long-term EEG monitoring market – New key sites were won in the US and other parts of the world as the Company continues its expansion into this new market • Asian business continues to grow – sales orders from Asia we
Slide 6: What was achieved in FY2013?
What was achieved in FY2013? For personal use only • Profitability restored at the EBITDA line - $0.3m compared to $(0.1)m in the previous year – benefit of positive impact from sales order shipments being caught up still to come in FY2014. NPAT was $(1.5)m compared to $(2.8)m in the prior year. • S
Slide 7: Revenue Composition at ≈$27m
Revenue ComposiAon at ≈$27m For personal use only By geographic region By product/market Tech. Supply Service, Europe, USA, Items, 10% Sleep, 31% 29% 10% 30% Brain Neuro, Asia, Aust, 9% Blood 20% Brain 20% Flow, Res, 19% 22% Compumedics sells directly to end-‐user customers in Australia, USA and Ge
Slide 8: Historical Revenues
Historical Revenues For personal use only Shipped and invoiced 35.0 30.0 25.0 20.0 15.0 10.0 5.0 0.0 2010 2011 2012 2013 F2014 Const Curr As Reported Forecast Sales shipped and invoiced in 2013 were impacted by an inability to ship due to restricted working capital.
Slide 9: Sales orders on hand
Sales orders on hand For personal use only 8 7 6 5 AUDm 4 3 2 1 0 2009 2010 2011 2012 2013 Orders on hand 1.2 2.4 2.6 6.4 7.3 With the working capital/funding issues resolved late in FY2013 it is expected carry forward sales orders on hand will decline to more normal levels of $1.0m to $2.0m.
Slide 10: Historical Earnings
Historical Earnings For personal use only NPAT EBITDA 4 5 3 4 2 3 1 2 0 2010 2011 2012 2013 F2014 1 -‐1 0 -‐2 -‐1 -‐3 -‐4 EBITDA EBITDA -‐ FX Adj NPAT NPAT -‐ FX adj Forecast Forecast NPAT and EBITDA in FY2012 and FY2013 were both adversely impacted by the inability to ship sales orders on ha
Slide 11: Cash, debt & operating cash
Cash, debt & operaAng cash For personal use only 3 2.5 2 1.5 1 0.5 0 2010 2011 2012 2013 Opera;ng cash Cash Debt
Slide 12: A Tradition of Innovation
A TradiAon of InnovaAon For personal use only Comperio DQ Summit IP SynAmps2 2004 2005 Somté 2003 2001 Siesta 802 Siesta 2000 2005 P Series 1994 S Series 1987 Somté PSG 2006 Neuvo LTM SynAmpsRT 2007 2008 CURRY6 2009 Somnilink SPAP Grael HD 2010 2010 Somté PSG 2.0 2011
Slide 13: Established Client Profile
Established Client Profile For personal use only
Slide 14: Strategic Value Roadmap
Strategic Value Roadmap For personal use only Core diagnos,c business Sleep – Es;mated global market USD150m Neurology – Es;mated global market USD450m Brain Research (Neuroscan) – Es;mated global market USD15m – new opportuni;es rapidly emerging Brain Blood Flow (DWL) – es;mated market USD15m, new
Slide 15: Growth strategies – Core business
Growth strategies – Core business For personal use only • Con;nue ini;al success and expansion into key neurological monitoring markets with par;cular emphasis on Long-‐term EEG monitoring (LTEM). • Expansion of the business, across all product lines, in Asia with par;cular emphasis on China as we
Slide 16: Strategic Growth Execution: Compumedics Clients in China
Strategic Growth ExecuAon Compumedics Clients in China For personal use only
Slide 17: Earnings improvement activities
Earnings improvement acAviAes For personal use only • Reloca;on of some manufacturing ac;vi;es to lower cost regions – China and Taiwan. • Con;nue to drive component purchasing to lower cost regions – China and Taiwan. • Streamlining of logis;cs (product delivery) and service and support as the busi
Slide 18: Strategic Value Roadmap
Strategic Value Roadmap For personal use only Core diagnos,c business Sleep – Es;mated global market USD150m Neurology – Es;mated global market USD450m Brain Research (Neuroscan) – Es;mated global market USD15m – new opportuni;es rapidly emerging Brain Blood Flow (DWL) – es;mated market USD15m, new
Slide 19: Medical Innovations – Sleep Treatment
Medical InnovaAons – Sleep Treatment For personal use only • The sleep treatment technology is the most advanced of these Medical Innova;on technologies • The SomniLink® SPAP® device has been developed in collabora;on with Medigas Italia S.r.l., Compumedics Italian distributor and also a significant
Slide 20: Medical Innovations – Sleep Treatment
Medical InnovaAons – Sleep Treatment For personal use only • About 20% of the adult popula;on globally suffer from some sleep issue. • The global apnoea devices market is es;mated at about USD8bn with expecta;ons it could reach close to $20bn by 2017. • Up to 100m people globally suffer from sleep apn
Slide 21: Medical Innovations – Driver Vigilance Assist
Medical InnovaAons – Driver Vigilance Assist For personal use only • Compumedics has unique sleep monitoring technology which has been used to research and develop proto-‐type systems for monitoring driver drowsiness • Fa;gue is one of the top three reasons for all road fatali;es • Car manufactures
Slide 22: Medical Innovations – Driver Vigilance Assist
Medical InnovaAons – Driver Vigilance Assist For personal use only • Market for this technology is very large – conserva;vely es;mated at $30m for the Australian market and up to USD15bn for the global market, based on annual vehicle produc;on of some 60m vehicles a year. • Compumedics owns patents
Slide 23: Medical Innovations – eHealth and on-line education
Medical InnovaAons – eHealth and on-‐line educaAon For personal use only • On-‐line educa,on targeted at neurology and specifically the Asia Pacific region – There is a growing prevalence of neurological disorders in the Asia region with a growing need for enhanced training and skills in the region
Slide 24: Medical Innovations – eHealth and on-line education
Medical InnovaAons – eHealth and on-‐line educaAon For personal use only • Tele-‐home and tele-‐hospital applica,ons for exis,ng Compumedics technologies – driven by government and insurers needs to reduce the costs of delivery health services to ageing popula;ons • Large markets – US market for
Slide 25: Strategic Growth Execution: Capitalization Pathways
Strategic Growth ExecuAon Capitaliza)on Pathways For personal use only The three principal paths available to Compumedics in order to implement the strategic growth drivers are: § Do it ourselves – recapitalize the group and implement the action plans for the strategic growth drivers ourselves (we
Slide 26: In conclusion
In conclusion For personal use only • Core business – refocus on sales and profit growth as Asia manufacturing cost reduc;ons and clearing the sales order back-‐log restore profitability to the Group • Medical Innova,ons – Commercialisa;on of main breakout plakorms: – Sleep treatment – Driver Vigilan
Slide 27: Ordinary Business
Ordinary Business For personal use only § Item 1 Financial Statements and Reports § Item 2 Election of Director – Mr. D. Lawson § Item 3 Adoption of Remuneration Report (non- binding resolution) § § Item 4 Appointment of Auditor
Slide 28: Meeting closes
Meeting closes For personal use only Refreshments and additional questions and discussion to continue in the main reception area for those interested.
Slide 29: OneMedForum 2011 - San Francisco
For personal use only OneMedForum 2011 - San Francisco Wednesday 12 January 2011